Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RespireRx Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
RespireRx Pharmaceuticals

RespireRx Pharmaceuticals

Public

Biopharmaceutical firm specializing in novel drug therapies for sleep apnea treatment.

HQ
Glen Rock, NJ, US
Founded
1987
Overview
Compare
Fundraising
Employees
Website

RespireRx Pharmaceuticals, founded with a mission to develop innovative drug therapies, focuses on treating sleep apnea and other neurological conditions. The company aims to improve patient outcomes through cutting-edge biopharmaceutical research. Their primary product, CX1739, is an AMPAkine designed to enhance respiratory function in sleep apnea patients and improve bladder function in individuals with spinal cord injuries.

Notable figures associated with RespireRx include leading researchers and industry experts in neurology and pharmacology. The company has secured significant funding, including a Department of Defense award for clinical studies on CX1739. RespireRx's preclinical research has shown promising results, positioning it as a key player in the biopharmaceutical sector with a potential to make substantial impacts on treating sleep apnea and related conditions.

RespireRx Pharmaceuticals - Similar Companies

Respira Therapeutics logo

Respira Therapeutics

Respirics logo

Respirics

Apnimed logo

Apnimed

apnimed.com

Axikin Pharmaceuticals logo

Axikin Pharmaceuticals

Respirogen logo

Respirogen

respirogen.com

Pulmatrix logo

Pulmatrix

pulmatrix.com

Pneuma Respiratory logo

Pneuma Respiratory

Response Pharmaceuticals logo

Response Pharmaceuticals

Resolvyx Pharmaceuticals logo

Resolvyx Pharmaceuticals

Resilience Therapeutics logo

Resilience Therapeutics

Kinaset Therapeutics logo

Kinaset Therapeutics

kinasettx.com

Aer Therapeutics logo

Aer Therapeutics

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Collegium Pharmaceutical logo

Collegium Pharmaceutical

CeNeRx Biopharma logo

CeNeRx Biopharma

cenerx.com

RespireRx Pharmaceuticals - Quick Facts

Who are RespireRx Pharmaceuticals' competitors?

Companies similar to RespireRx Pharmaceuticals include Respira Therapeutics, Respirics, Apnimed and Axikin Pharmaceuticals.

When was RespireRx Pharmaceuticals founded?

RespireRx Pharmaceuticals was founded in 1987.

Where is RespireRx Pharmaceuticals' headquarters located?

RespireRx Pharmaceuticals' headquarters is located in Glen Rock, NJ, US.

When was RespireRx Pharmaceuticals' last funding round?

RespireRx Pharmaceuticals' most recent funding round was for $238.5k (USD) in November 2014.

How much has RespireRx Pharmaceuticals raised to-date?

As of Nov 17, 2014, RespireRx Pharmaceuticals has raised a total of $12.2M (USD).

How many employees does RespireRx Pharmaceuticals have?

RespireRx Pharmaceuticals has 2 employees as of Feb 6, 2024.

RespireRx Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 19 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research